Emam, Hadidja A.

HRN: 22-93-11  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/17/2023
CEFTRIAXONE 1G (VIAL)
04/17/2023
04/24/2023
IV
2g
Q24h
T/c Sepsis
Waiting Final Action 
04/17/2023
CEFTRIAXONE 1G (VIAL)
04/17/2023
04/24/2023
IVTT
2g
Q12
Sepsis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: